Search results
Results from the WOW.Com Content Network
Immunoglobulin therapy is the use of a mixture of antibodies (normal human immunoglobulin) to treat several health conditions. [13] [14] These conditions include primary immunodeficiency, immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain–Barré syndrome, and certain other infections when a ...
Age >56: thymoma, lymphoid malignancies, side effects of medications (particularly anticonvulsants and anti-rheumatics), loss of immunoglobulin due to renal/gut disease [1] Treatment: Immunoglobulin replacement therapy, symptom management: Prognosis
Treatment for combined immunodeficiencies with defects in antibody production primarily consists of immunoglobulin replacement therapy. [1] Susceptibility to infections is an important feature of combined immunodeficiencies and influences patients' clinical evolution; as a result, antimicrobial prophylaxis is frequently used to prevent ...
Testosterone Replacement Therapy: What to Know Before Starting Even the word alone sounds manly. For men, testosterone is important for drive, fertility, heart health, bone health, energy and mood ...
In the case of humoral immune deficiency, immunoglobulin replacement therapy in the form of intravenous immunoglobulin (IVIG) or subcutaneous immunoglobulin (SCIG) may be available. Antibiotic prophylaxis is also commonly used to prevent respiratory tract infections in these patients. [12]
Omalizumab is the drug therapy used to deliver the anti-immunoglobulin E antibodies. Omalizumab is a human anti-IgE monoclonal antibody. It blocks IgE-mediated reactions and reduces asthma symptoms by binding to free IgE antibodies in serum. The drug is delivered every 2-4 weeks depending on severity of the patient.
GH therapy should begin “at the most reasonably early point in the patient's growth when they're identified to be growth hormone deficient or have idiopathic short stature,” says Khatoon.
Rh immune globulin is composed of IgG antibodies and therefore is able to cross the placenta. In rare cases this can cause a baby to have a weakly positive direct antiglobulin test (DAT) due to sensitization of fetal cells from mothers who have received multiple doses of RhIG. However, no treatment is necessary as the clinical course is benign ...